Stocks Overview

LAST PRICE
2.2900
TODAY'S CHANGE (%)
Trending Down-0.0100 (-0.4348%)

Bid / Lots
2.2000/ 1
Ask / Lots
2.3700/ 1
Open / Previous Close
2.2900 / 2.3000
Day Range
Low 2.2200
High 2.3700
52 Week Range
Low 1.2100
High 4.1598
Volume
959,809
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Friday's close: 2.3
Time	Volume	NUVB
09:32 ET	5433	2.295
09:33 ET	25700	2.25
09:35 ET	6541	2.23
09:37 ET	7721	2.26
09:39 ET	7944	2.27
09:42 ET	2215	2.25
09:44 ET	26454	2.22
09:46 ET	2547	2.235
09:48 ET	2751	2.2499
09:50 ET	408	2.245
09:51 ET	900	2.24
09:53 ET	500	2.245
09:55 ET	2782	2.24
09:57 ET	2602	2.245
10:00 ET	713	2.245
10:02 ET	10734	2.245
10:04 ET	5317	2.265
10:06 ET	3502	2.255
10:08 ET	620	2.25
10:09 ET	400	2.255
10:11 ET	813	2.255
10:13 ET	420	2.255
10:15 ET	400	2.255
10:18 ET	4175	2.275
10:20 ET	598	2.275
10:22 ET	400	2.28
10:24 ET	2623	2.295
10:26 ET	200	2.295
10:27 ET	10290	2.295
10:29 ET	2238	2.29
10:31 ET	300	2.295
10:33 ET	100	2.295
10:36 ET	1085	2.295
10:38 ET	300	2.295
10:40 ET	3413	2.295
10:42 ET	937	2.29
10:44 ET	200	2.295
10:45 ET	100	2.295
10:47 ET	1661	2.285
10:49 ET	6049	2.31
10:51 ET	1000	2.31
10:54 ET	200	2.32
10:56 ET	2265	2.32
11:00 ET	4109	2.315
11:02 ET	500	2.3199
11:03 ET	3209	2.325
11:05 ET	6796	2.325
11:07 ET	1432	2.325
11:09 ET	400	2.325
11:12 ET	6214	2.345
11:14 ET	2333	2.36
11:16 ET	600	2.37
11:18 ET	400	2.37
11:20 ET	5229	2.335
11:21 ET	1995	2.34
11:23 ET	100	2.34
11:25 ET	1886	2.34
11:27 ET	100	2.34
11:30 ET	210	2.34
11:32 ET	865	2.338
11:34 ET	275	2.3354
11:38 ET	2054	2.345
11:39 ET	400	2.35
11:41 ET	4174	2.335
11:43 ET	4000	2.335
11:45 ET	2468	2.335
11:48 ET	417	2.335
11:50 ET	100	2.335
11:52 ET	3895	2.325
11:54 ET	1999	2.335
11:56 ET	200	2.34
11:59 ET	1200	2.335
12:01 ET	4810	2.34
12:03 ET	5649	2.335
12:06 ET	1362	2.33
12:08 ET	100	2.33
12:10 ET	700	2.33
12:12 ET	1747	2.325
12:14 ET	200	2.325
12:15 ET	7396	2.335
12:17 ET	242	2.335
12:19 ET	2300	2.32
12:21 ET	100	2.325
12:24 ET	1422	2.33
12:26 ET	1200	2.33
12:28 ET	529	2.335
12:30 ET	1500	2.335
12:32 ET	500	2.34
12:33 ET	4155	2.35
12:35 ET	1204	2.345
12:37 ET	1300	2.35
12:39 ET	1105	2.35
12:42 ET	2185	2.36
12:44 ET	2534	2.36
12:46 ET	500	2.355
12:48 ET	1700	2.355
12:50 ET	600	2.36
12:51 ET	700	2.36
12:53 ET	3203	2.36
12:55 ET	1497	2.355
12:57 ET	7065	2.345
01:00 ET	2165	2.345
01:02 ET	200	2.345
01:04 ET	700	2.345
01:06 ET	500	2.35
01:08 ET	7298	2.36
01:09 ET	1500	2.36
01:11 ET	1500	2.36
01:13 ET	2000	2.35
01:15 ET	1200	2.35
01:18 ET	1841	2.36
01:20 ET	2100	2.36
01:22 ET	1500	2.36
01:24 ET	18188	2.3227
01:26 ET	1300	2.325
01:27 ET	100	2.325
01:31 ET	700	2.33
01:33 ET	8176	2.335
01:36 ET	700	2.34
01:38 ET	5202	2.33
01:42 ET	500	2.33
01:44 ET	100	2.335
01:45 ET	4217	2.3208
01:47 ET	100	2.32
01:49 ET	100	2.325
01:51 ET	1300	2.325
01:56 ET	900	2.325
01:58 ET	500	2.325
02:00 ET	4577	2.325
02:02 ET	300	2.325
02:05 ET	100	2.325
02:09 ET	300	2.325
02:12 ET	100	2.325
02:14 ET	548	2.325
02:16 ET	400	2.33
02:18 ET	300	2.33
02:20 ET	621	2.3245
02:21 ET	959	2.33
02:23 ET	200	2.33
02:25 ET	2141	2.32
02:27 ET	600	2.33
02:30 ET	3482	2.315
02:32 ET	200	2.315
02:34 ET	7009	2.325
02:36 ET	1579	2.32
02:38 ET	200	2.325
02:39 ET	600	2.32
02:41 ET	617	2.325
02:43 ET	3460	2.315
02:45 ET	4163	2.3
02:48 ET	500	2.305
02:50 ET	1198	2.3
02:52 ET	300	2.305
02:54 ET	3372	2.3
02:56 ET	300	2.305
02:57 ET	6900	2.315
02:59 ET	2909	2.325
03:01 ET	100	2.325
03:03 ET	1490	2.32
03:06 ET	1000	2.33
03:08 ET	800	2.33
03:10 ET	10653	2.325
03:12 ET	2470	2.33
03:14 ET	600	2.325
03:15 ET	400	2.325
03:17 ET	7300	2.32
03:19 ET	200	2.32
03:21 ET	100	2.32
03:24 ET	737	2.315
03:26 ET	1300	2.315
03:28 ET	8289	2.335
03:30 ET	1100	2.335
03:32 ET	200	2.335
03:33 ET	1266	2.33
03:35 ET	1299	2.33
03:37 ET	6738	2.325
03:39 ET	600	2.325
03:42 ET	1955	2.325
03:44 ET	24542	2.31
03:46 ET	5790	2.3
03:48 ET	12567	2.29
03:50 ET	21839	2.3
03:51 ET	3850	2.3
03:53 ET	20219	2.3
03:55 ET	17335	2.295
03:57 ET	24054	2.305
04:00 ET	194440	2.29

Data delayed at least 15 minutes.

Oct 22, 2024
- DJ Nuvation Bio Price Target Maintained With a $5.00/Share by Wedbush, from 10:59AM ET on Tuesday Oct 22, 2024 by Dow Jones
  10:59AM ET on Tuesday Oct 22, 2024 by Dow Jones
Oct 7, 2024
- DJ Nuvation Bio Names Philippe Sauvage Chief Financial Officer, from 4:21PM ET on Monday Oct 07, 2024 by Dow Jones
  4:21PM ET on Monday Oct 07, 2024 by Dow Jones
- *DJ Nuvation Bio Appoints Industry Veteran Philippe Sauvage As Chief Financial Officer >NUVB, from 4:05PM ET on Monday Oct 07, 2024 by Dow Jones
  4:05PM ET on Monday Oct 07, 2024 by Dow Jones
- Nuvation Bio Appoints Industry Veteran Philippe Sauvage as Chief Financial Officer, from 4:05PM ET on Monday Oct 07, 2024 by Dow Jones
  4:05PM ET on Monday Oct 07, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesNUVB Nuvation Bio Inc	766.6M	-1.1x	---
United StatesANNX Annexon Inc	749.1M	-5.8x	---
United StatesERAS Erasca Inc	810.8M	-3.1x	---
United StatesLENZ LENZ Therapeutics Inc	781.7M	-3.0x	---
United StatesBIOA BIOAGE Labs Inc	771.2M	-12.4x	---
United StatesREPL Replimune Group Inc	821.2M	-3.7x	---
As of 2024-11-05

Nuvation Bio Inc. is a biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. The Company is advancing multiple clinical-stage candidates, including a ROS1 inhibitor, a mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor, a bromodomain and extra-terminal (BET) inhibitor, and a drug-drug conjugate (DDC). Its portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Taletrectinib is an oral, potent, CNS-active, selective, ROS1 inhibitor specifically designed for the potential treatment of ROS1-positive non-small cell lung cancer (NSCLC). Safusidenib is an oral, potent, targeted inhibitor of mIDH1 being evaluated in a global Phase II trial in patients with low-grade IDH1-mutant glioma. NUV-868 is a BD2-selective oral small molecule BET inhibitor, that inhibits BRD4. It is conducting Phase I/II study of NUV-1511.

Contact Information

Headquarters: 357 Tehama Street, Floor 3SAN FRANCISCO, CA, United States 94103
Phone: 415-754-3517
Fax: 302-636-5454

Executives

Independent Chair of the Board: Daniel Welch
President, Chief Executive Officer, Founder, Director: David Hung
Chief Financial Officer and Principal Financial Officer: Philippe Sauvage
Chief Executive Officer of AnHeart Therapeutics and Director: Junyuan Wang
Chief People Officer: Stacy Markel

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table

Market Cap	$770.0M
Revenue (TTM)	$1.4M
Shares Outstanding	334.8M
Nuvation Bio Inc does not pay a dividend.


Beta	1.35
EPS	$-2.11
Book Value	$2.76
P/E Ratio	-1.1x
Price/Sales (TTM)	536.6
Price/Cash Flow (TTM)	---
Operating Margin	-37,474.14%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Nuvation Bio Inc
NYSE:NUVBUnited States

Search Criteria

Charts

Recent News

Oct 22, 2024

DJ Nuvation Bio Price Target Maintained With a $5.00/Share by Wedbush, from 10:59AM ET on Tuesday Oct 22, 2024 by Dow Jones

Oct 7, 2024

DJ Nuvation Bio Names Philippe Sauvage Chief Financial Officer, from 4:21PM ET on Monday Oct 07, 2024 by Dow Jones

*DJ Nuvation Bio Appoints Industry Veteran Philippe Sauvage As Chief Financial Officer >NUVB, from 4:05PM ET on Monday Oct 07, 2024 by Dow Jones

Nuvation Bio Appoints Industry Veteran Philippe Sauvage as Chief Financial Officer, from 4:05PM ET on Monday Oct 07, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar